Novel method can efficiently create several “building blocks” of pharmaceutical drugs

Several drugs, including those for depression, schizophrenia, and malaria, would not be if not for a type of organic chemical compound called alicyclic compounds. These compounds are 3D structures formed when three or more carbon atoms join in a ring via covalent bonds, but the ring is not aromatic.

Aromatic compounds (or arenes) are another class of organic compounds which are 2D structures with reactive properties distinct from those of alicyclic compounds. A well-known example is benzene, the six-carbon ring comprising alternating single- and double-bonds between the carbon atoms.

By dearomatizing arenes, one can get alicyclic compounds. In fact, this dearomatization is one of the most powerful ways of obtaining alicyclic compounds. But some of the most abundantly available arenes, such as benzene and naphthalene, are very stable, and breaking them up to construct alicyclic compounds has been challenging. With existing methods, often large amounts of reactants yield very little product.

“The highly efficient conversion of readily and commercially available arenes to high value-added alicyclic compounds could accelerate drug discovery research by leaps,” say Assistant Professor Kei Muto and Professor Junichiro Yamaguchi of Waseda University, Japan, who led the discovery of a novel efficient method. Their study is published in the Royal Society of Chemistry’s Chemical Science.

In the novel method, bromoarenes are reacted with two other classes of organic compounds, diazo compounds and malonates, in the presence of a palladium catalyst (compound that enables a chemical reaction), under optimal conditions of concentration, temperature, and time (experimentally ascertained in the study). Subsequently, good amounts of the corresponding alicyclic compounds are produced.

“What is really special about this method is that a range of bromoarenes, including benzenoids, azines, and heteroles, can be converted to their alicyclic counterparts,” Muto says. He speaks also of the key portions of an alicyclic molecule that give it complexity and utility—the functional groups attached to the cyclic carbons. He says, “The obtained compounds have functional groups at two points in the cyclic chain, and these can be easily diversified through further reactions to yield a variety of highly functionalized 3D molecules.”

The use of malonates as reactant is what allows this multi-functionalization, setting this novel method apart from existing methods, which are often highly specific in terms of the products possible. Because malonates are known to predominantly react with palladium-benzyl complexes, the use of a palladium-based catalyst became key to the success of this method. The palladium catalyst led to the formation of a benzyl–palladium intermediate that could then react with malonates, producing the final multi-functionalized alicyclic products.

Thus, designing an appropriate catalysis process was essential to developing the aromatic-to-alicyclic transformation technique. “Next, we would like to design new catalysts to make this reaction more general; that is, compatible with a broader range of arenes,” says Yamaguchi.

With their future plans in place, Muto and Yamaguchi are confident of the good that their team’s work can do in the world: “We believe this organic reaction will help drug discovery research finally ‘escape from the flatland’ of the simpler and 2D aromatic compounds, so to speak, thereby advancing medicinal chemistry significantly.”

2D bromoarenes were reacted with diazo compounds and malonates in the presence of a palladium catalyst to yield highly functionalized 3D alicyclic compounds, which are extremely prominent in pharmaceuticals.

Photo courtesy: Junichiro Yamaguchi

Reference

Authors: Hiroki Kato1, Itsuki Musha1, Masaaki Komatsuda1, Kei Muto2, and Junichiro Yamaguchi2

Title of original paper: Catalytic Three-component C–C Bond Forming Dearomatization of Bromoarenes with Malonates and Diazo Compounds

Journal: Chemical Science

DOI: https://doi.org/10.1039/D0SC02881A

Affiliations:
1Department of Applied Chemistry, Waseda University, 513, Tsurumakicho, Shinjuku, Tokyo 162-0041, Japan.
2Waseda Institute for Advanced Study, Waseda University, 513, Tsurumakicho, Shinjuku, Tokyo 162-0041, Japan.

About Waseda University

Waseda University is a leading private, non-profit institution of higher education based in central Tokyo, with over 50,000 students in 13 undergraduate and 20 graduate schools. Founded in 1882, Waseda cherishes three guiding principles: academic independence, practical innovation and the education of enlightened citizens. Established to mold future leaders, Waseda continues to fulfill this mission, counting among its alumni seven prime ministers and countless other politicians, business leaders, journalists, diplomats, scholars, scientists, actors, writers, athletes and artists. The University is also number one in Japan in international activities, including the number of international students, with the broadest range of degree programs fully taught in English.

Share this Post:

Related Articles

Priming the Pump: Recent Design Breakthrough...

August 25, 2020

Lasers are an endless source of interest for scientists and engineers alike. This is because the advent of advan...

Know More

New Study Shows How Infrared Lasers...

August 5, 2020

A notable characteristic of several neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, is the form...

Know More

How the Regulator is Regulated—Insight into...

July 21, 2020

In immune-related disorders, therapy often involves identifying the molecules responsible for immune dysregulati...

Know More

Leave a Reply

Your email address will not be published. Required fields are marked *

X
X
Download White Paper






    X
    Let's Talk